2025-12-19 - Analysis Report
Okay, here's a breakdown of SDGR (Schrodinger Inc.) based on the provided data, followed by a comprehensive analysis.

**Schrodinger Inc. Overview:** Schrodinger Inc. is a company focused on providing computational solutions to accelerate drug discovery and materials science research.

**1. Return Rate Comparison and Alpha/Beta Analysis**

*   **SDGR Cumulative Return:** -57.11%
*   **VOO (S&P 500) Cumulative Return:** 67.25%
*   **Divergence:** -123.2 (Relative Divergence: 2.3)

**Analysis:** SDGR has significantly underperformed the S&P 500. The current divergence is very negative, placing it near the bottom of its historical divergence range relative to the S&P 500.  A relative divergence of 2.3 indicates that this divergence is near the minimum end of its historical fluctuation.

**Alpha/Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2020-2022  | -70.0%  | 78.2% | -76.0% | 0.0 | 1.4    |
| 2021-2023  | -57.0%  | 81.0% | -59.0% | -0.0 | 2.6    |
| 2022-2024  | 6.0%   | 81.0% | -14.0% | -0.0 | 1.4    |
| 2023-2025  | -5.0%   | 82.6% | -69.0% | -0.0 | 1.3    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate is negative in most periods.
*   **MDD:** Maximum Drawdown is very high, indicating significant volatility and potential losses for investors during these periods.
*   **Alpha:** The negative Alpha values across all periods suggest that SDGR has consistently underperformed relative to its expected return based on its beta.
*   **Beta:** Beta is approximately 0.0 in all cases.
*   **Market Cap:** Market Cap (in Billions) is relatively low.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** $17.20
*   **Last Market Data:** Price $17.20, Previous Close $17.4, Change -1.15%
*   **5-day SMA:** $17.76
*   **20-day SMA:** $17.51
*   **60-day SMA:** $19.06

**Analysis:** The stock price is currently below all three Simple Moving Averages (SMA). This could indicate a short-term downward trend. The recent negative change in price is also noteworthy.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommendation)
*   **RSI:** 43.92 (Neutral, neither overbought nor oversold)
*   **PPO:** 0.3968
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90)" suggests a strong buy signal.
*   **Recent Relative Divergence Change:** +1.0 (Short-term increase)
*   **Expected Return:** -2764.5% (Extremely negative, suggesting significant long-term risk)

**Analysis:**

*   The MRI suggests a medium investment recommendation.
*   The RSI is neutral, indicating that the stock is not currently overbought or oversold.
*   Recent relative divergence indicates a recent positive price change, which is not reflected in the other indicators.
*   The extremely negative Expected Return raises serious concerns about the long-term investment viability of SDGR.

**4. Recent News & Significant Events:**

*   **Bullish Headlines:** Multiple headlines indicate positive analyst sentiment, including an upgrade by B of A Securities, a "Buy the Bottom" recommendation, and a new price target of $24.
*   **Mixed Headlines:** One headline mentions a consensus rating of "Hold."
*   **Seeking Alpha:** The article on Seeking Alpha discusses unlocking hidden value in Schrodinger's Box.

**Analysis:** Recent news presents a mixed picture. Analyst upgrades and positive articles from Yahoo Finance and Simply Wall St. suggest some optimism. However, the "Hold" consensus and a Seeking Alpha article mentioning "Hidden Value" could indicate some skepticism or an expectation that significant value hasn't yet been realized.

**4-2. Analyst Opinions**

*   **Consensus:** Strong Buy (Mean: 1.44)
*   **Opinions:** 9
*   **Target Price:** Avg: $27.22, High: $33.00, Low: $18.00

**Analysis:**  Analysts, on average, have a "Strong Buy" consensus and a target price considerably higher than the current price. This suggests they believe the stock is undervalued. However, it's important to consider the range of target prices, as the low target is closer to the current price.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-11-05 | -0.45 | 0.05 B$  |
| 2025-08-06 | -0.59 | 0.05 B$  |
| 2025-05-07 | -0.82 | 0.06 B$  |
| 2024-11-12 | -0.52 | 0.04 B$  |
| 2025-11-05 | -0.52 | 0.04 B$  |

**Analysis:** Schrodinger has reported consistent losses per share (EPS) and relatively stable revenue in the provided quarters. These negative earnings contribute to the stock's underperformance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $0.05B  | 51.61%        |
| 2025-06-30 | $0.05B  | 47.77%        |
| 2025-03-31 | $0.06B  | 52.26%        |
| 2024-12-31 | $0.09B  | 72.61%        |
| 2024-09-30 | $0.04B  | 50.24%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-09-30 | $0.32B  | -10.21% |
| 2025-06-30 | $0.34B  | -12.59% |
| 2025-03-31 | $0.37B  | -16.01% |
| 2024-12-31 | $0.42B  | -9.54%  |
| 2024-09-30 | $0.45B  | -8.49%  |

**Analysis:** Revenue is fluctuating, but the profit margins look quite high. However, the negative Return on Equity (ROE) indicates that the company is not generating profits from shareholder equity. Declining equity also raises concern.

**7. Comprehensive Analysis (Summary):**

SDGR has significantly underperformed the S&P 500. The stock is trading below its moving averages, suggesting a short-term downward trend. The Market Risk Indicator is neutral, but the expected return is exceptionally negative, pointing to significant long-term risks. Recent analyst ratings are mostly positive. However, this conflicts with a consensus rating of "Hold" and weak earnings.

**Overall Recommendation:**

Despite positive analyst ratings and recent news, caution is warranted. The extremely negative expected return, consistent losses, and negative ROE are significant red flags. A "Hold" rating would be appropriate, and further investigation into the underlying reasons for the company's financial struggles is highly recommended before making any investment decisions. Investors should closely monitor the company's earnings reports and revenue growth and consider the risks associated with a company with a negative ROE and a history of underperformance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.